Today's Market Winners and Losers

Investing

Published: August 31, 2012 11:06 am

Last Updated: April 28, 2020 7:49 am

Stocks are up Friday, with the Dow Jones Industrial Average up 1.06%, the Nasdaq up 0.74% and the S&P 500 up 0.82%. Friday’s winners include a company beating second-quarter earnings and a biotech firm soon to announce results for a clincal trial. The loser had its price target cut by a prominent analyst.

These are Friday’s market winners and loser.

Biggest Winners

Shares of Splunk, Inc. (NASDAQ: SPLK) are up 17.93% to $35.97 on trading volume of 1.9 million shares. While the data-mining software company reported a second-quarter loss of 1 cent a share, it was better than Wall Street expectations of a 4-cent-a-share loss. The 52-week high is $37.57.

Shares of StemCells Inc. (NASDAQ: STEM) are up 12.24% to $2.20 on trading volume of 5 million shares. The biotechnology company’s stock is rallying before it announces results of a clinical durg trial to treat chronic spinal cord injury. The 52-week high is $2.55.

Biggest Loser

Shares of Facebook Inc. (NASDAQ: FB) are down 3.92% to $18.34 on trading volume of 25.5 million shares. BMO Capital has cut its price target to $15. Before Friday, the 52-week low was $18.75.

Samuel Weigley

Follow him on Twitter: SWeigley

Get Ready To Retire ^(Sponsored)

Start by taking a quick retirement quiz from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes, or less.

Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.

Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future